Advertisement

Index by author

September 01, 1987; Volume 15,Issue 5

  1. Kahn, C

    1. Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;

  2. Kane, R F

    1. Influence of gonadal hormones upon rat hepatic acetaminophen sulfotransferases.
      R F Kane and L J Chen
      Drug Metabolism and Disposition September 1987, 15 (5) 725-728;

  3. Kau, D

    1. Disposition of the monoclonal antibody-vinca alkaloid conjugate, KS1/4-DAVLB (LY256787), in Fischer 344 rats and rhesus monkeys.
      M E Spearman, R M Goodwin and D Kau
      Drug Metabolism and Disposition September 1987, 15 (5) 640-647;

  4. Kelley, J A

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

  5. Khalique, A

    1. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
      S M Somani and A Khalique
      Drug Metabolism and Disposition September 1987, 15 (5) 627-633;

  6. Landi, M S

    1. Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;

  7. Lee, F W

    1. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

  8. Litterst, C L

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

  9. Maddox, M L

    1. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

  10. Malet-martino, M C

    1. Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.
      J P Vialaneix, M C Malet-Martino, J S Hoffmann, J Pris and R Martino
      Drug Metabolism and Disposition September 1987, 15 (5) 718-724;
« Previous (Pages : 1 2 3 4 5 6 7 8 9 ... 9) Next »
Back to top

In this issue

Advertisement